Geode Capital Management
MRNA icon

Geode Capital Management’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$244M Buy
8,877,280
+1,420,690
+19% +$39.1M 0.02% 601
2025
Q1
$211M Buy
7,456,590
+215,236
+3% +$6.08M 0.02% 621
2024
Q4
$300M Buy
7,241,354
+171,774
+2% +$7.12M 0.02% 516
2024
Q3
$471M Buy
7,069,580
+178,115
+3% +$11.9M 0.04% 389
2024
Q2
$816M Buy
6,891,465
+140,986
+2% +$16.7M 0.07% 247
2024
Q1
$718M Buy
6,750,479
+201,018
+3% +$21.4M 0.07% 275
2023
Q4
$649M Buy
6,549,461
+134,452
+2% +$13.3M 0.07% 274
2023
Q3
$661M Buy
6,415,009
+112,512
+2% +$11.6M 0.08% 241
2023
Q2
$764M Buy
6,302,497
+57,540
+0.9% +$6.97M 0.09% 213
2023
Q1
$957M Buy
6,244,957
+77,265
+1% +$11.8M 0.12% 147
2022
Q4
$1.11B Sell
6,167,692
-80,119
-1% -$14.4M 0.16% 122
2022
Q3
$738M Sell
6,247,811
-89,880
-1% -$10.6M 0.11% 169
2022
Q2
$904M Sell
6,337,691
-98,663
-2% -$14.1M 0.13% 139
2022
Q1
$1.11B Buy
6,436,354
+403,891
+7% +$69.4M 0.14% 128
2021
Q4
$1.53B Buy
6,032,463
+272,502
+5% +$69M 0.18% 93
2021
Q3
$2.21B Buy
5,759,961
+2,404,103
+72% +$923M 0.3% 59
2021
Q2
$787M Sell
3,355,858
-450,572
-12% -$106M 0.11% 162
2021
Q1
$498M Buy
3,806,430
+235,190
+7% +$30.8M 0.08% 258
2020
Q4
$373M Buy
3,571,240
+206,455
+6% +$21.5M 0.06% 300
2020
Q3
$238M Buy
3,364,785
+36,749
+1% +$2.6M 0.05% 356
2020
Q2
$214M Buy
3,328,036
+674,217
+25% +$43.3M 0.05% 368
2020
Q1
$79.5M Buy
2,653,819
+320,551
+14% +$9.6M 0.02% 573
2019
Q4
$45.6M Buy
2,333,268
+99,167
+4% +$1.94M 0.01% 1007
2019
Q3
$35.6M Buy
2,234,101
+1,942,210
+665% +$30.9M 0.01% 1087
2019
Q2
$4.27M Buy
291,891
+11,755
+4% +$172K ﹤0.01% 2499
2019
Q1
$5.7M Buy
280,136
+77,644
+38% +$1.58M ﹤0.01% 2257
2018
Q4
$3.09M Buy
+202,492
New +$3.09M ﹤0.01% 2513